Biotechnology & Pharmaceuticals Roundtable 2016 discusses landmark case precedents including a first-of-its-kind verdict in one jurisdiction, along with providing details on which country is considered to be ‘active and attractive’ in mergers & acquisition opportunities. Other highlighted topics include a summary of the latest regulatory changes including the introduction of a streamlined unitary patent scheme across the European Union. Featured countries are: Brazil, Australia, Sweden, and United Kingdom.